“Buying in the Indian market has become increasingly selective, with investors favouring pharmaceuticals, telecom, realty and consumer durables. Beyond the Nifty 50, we see opportunities in mid- and small-cap stocks, particularly in select pharmaceutical, auto-ancillary and capital expenditure-linked companies,” said Prasenjit Paul, fund manager at 129 Wealth and research analyst at Paul Asset.
